Anal Canal Cancer clinical trials

Explore recruiting anal canal cancer clinical trials.

Recruiting anal canal cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Anal Canal Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

INCMGA 0012-303: A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2)

Germany, France, Norway, Denmark, Sweden, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

INTERACT-ION : Ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin and 5-fluorouracil) followed by chemoradiotherapy in patients with stage III squamous cell anal carcinoma. A phase II study.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 1/2 multiple-indication biomarker, safety, and efficacy study in advanced or metastatic Gastrointestinal cancers exploring treatment comBinations with peLarEorep and aTezolizumab (GOBLET)

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Anal Canal Cancer trials by city

Anal Canal Cancer in Toronto Anal Canal Cancer in Vancouver Anal Canal Cancer in Montreal Anal Canal Cancer in Calgary Anal Canal Cancer in Edmonton Anal Canal Cancer in Ottawa Anal Canal Cancer in Winnipeg Anal Canal Cancer in Quebec City Anal Canal Cancer in Hamilton Anal Canal Cancer in Kitchener Anal Canal Cancer in London Anal Canal Cancer in Halifax Anal Canal Cancer in New York Anal Canal Cancer in Los Angeles Anal Canal Cancer in Chicago Anal Canal Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease